ArticleJHEP reports : innovation in hepatology2021

Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B.

Laurens A van Kleef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.